Utility of Bromelain and N-Acetylcysteine in Treatment of Peritoneal Dissemination of Gastrointestinal Mucin-Producing Malignancies

This volume will describe both growth-inhibitory and mucin-depleting effects of bromelain and N-acetylcysteine, on their own or in combination, in cancer. It will coherently review the pathophysiological aspects of the mucin glycoproteins in malignancies and provide an updated account of the status of bromelain and N-acetylcysteine in cancer therapy.

The volume will develop the idea of using these two drugs as a combination formulation for mucin-depleting effects.

Comprehensively explores both growth-inhibitory and mucin-depleting effects of bromelain and N-acetylcysteine, on their own or in combination, in cancer Deftly complies and evaluates the pathophysiological aspects of the mucin glycoproteins in malignancies Provides an updated account of the status of bromelain and N-acetylcysteine in cancer therapy Includes supplementary material: sn.pub/extras

Autorentext

Afshin Amini is MD, PhD at Department of Surgery, Research and Education Center, St. George Hospital, The University of New South Wales, Sydney, Australia. David L. Morris is Professor, The University of New South Wales, Head, Department of Surgery, St. George Hospital, NSW, Australia Samar Masoumi-Moghaddam is MD, PhD at Department of Surgery, Research and Education Center, St. George Hospital, The University of New South Wales, Sydney, Australia.

Inhalt
1 Peritoneal dissemination of gastrointestinal tumors.- 2 Mucins and tumor biology.- 3 Bromelain.- 4 N-acetylcysteine.- 5 A novel approach to peritoneal dissemination of mucin-expressing malignancies of gastrointestinal origin.- Summary and future potential directions.